deepc announces partnership with Qure.ai

We are pleased to announce the latest addition to deepcOS - Qure.ai. The company’s diverse AI portfolio encompasses X-ray and CT solutions.  

• qER is an AI-enabled head CT tool widely deployed across emergency rooms to expedite the detection, triage, and quantification of traumatic brain injuries, strokes, intracranial hemorrhage (& its subtypes), cranial fracture, midline shift, mass effect, and more on non-contrast head CT scans. With qER, relevant clinicians in an ER system can identify suspected stroke cases/internal injuries much earlier than in conventional settings, enabling seamless collaboration and faster, more accurate decision-making. 
• qCT harnesses AI to facilitate easy detection of lung nodules in lung cancer pathways on Chest CT scans. It also enables comprehensive analysis of characterization, and progression monitoring of lung nodules (ranging from 3mm to 30mm) to support faster treatment planning. 
• qXR aids clinicians in detecting multiple abnormal findings on a chest X-ray in less than 1 minute. It segregates pathological scans from non-pathological ones, detecting abnormalities (including lung opacities, nodules, consolidations, and injuries like pneumothorax and rib fractures) in the lungs, pleura, mediastinum, bones, diaphragm, and heart.  
• qMSK can detect fractures in X-ray scans of 15 anatomies (ribs, clavicle, shoulder, humerus, elbow, forearm, wrist, hand, hip, pelvis, femur, knee, tibia/fibula, ankle, and foot) of adult patients. It can be used in radiology departments, emergency rooms, and primary care centres acting as a reliable first reader or offering a second pair of 'digital' eyes on more challenging, suspicious cases to reduce the chances of late diagnoses, underdiagnoses, and even potential misdiagnoses to deliver better patient care. 

Discover some of the benefits of these AI solutions:

• Reduces turn-around time for critical cases 
• Improves productivity and accuracy 
• Improves inter-reader agreement for nodule malignancy 
• Validated in large-scale studies 
• Seamless integration with existing and new systems 
• Qure’s FDA and CE Class IIb cleared solutions are present in 2100+ sites, impacting 16 million lives globally ‍

‍“We believe that the Qure.ai and deepc collaboration is a fantastic opportunity to support healthcare systems further, simplifying radiological diagnostics and enhancing patient care. This aligns with the proactive push for AI-enabled healthcare across the NHS and healthcare delivery systems.” - Darren Stephens, SVP & Commercial Head UK & EU at Qure.ai

Together with our partners, we are pioneering the future of AI Solutions, revolutionizing the radiology industry.